PURPOSE: Magnetic iron oxide nanoparticles (MNPs) are used as contrast agents for magnetic resonance imaging (MRI) and hyperthermia for cancer treatment. The relationship between MRI signal intensity and cellular iron concentration for many new formulations, particularly MNPs having magnetic properties designed for heating in hyperthermia, is lacking. In this study, we examine the correlation between MRI T2 relaxation time and iron content in cancer cells loaded with various MNP formulations. MATERIALS AND METHODS: Human prostate carcinoma DU-145 cells were loaded with starch-coated bionised nanoferrite (BNF), iron oxide (Nanomag® D-SPIO), Feridex™, and dextran-coated Johns Hopkins University (JHU) particles at a target concentration of 50 pg Fe/cell using poly-D-lysine transfection reagent. T2-weighted MRI of serial dilutions of these labelled cells was performed at 9.4 T and iron content quantification was performed using inductively coupled plasma mass spectrometry (ICP-MS). Clonogenic assay was used to characterise cytotoxicity. RESULTS: No cytotoxicity was observed at twice the target intracellular iron concentration (∼100 pg Fe/cell). ICP-MS revealed highest iron uptake efficiency with BNF and JHU particles, followed by Feridex and Nanomag-D-SPIO, respectively. Imaging data showed a linear correlation between increased intracellular iron concentration and decreased T2 times, with no apparent correlation among MNP magnetic properties. CONCLUSIONS: This study demonstrates that for the range of nanoparticle concentrations internalised by cancer cells the signal intensity of T2-weighted MRI correlates closely with absolute iron concentration associated with the cells. This correlation may benefit applications for cell-based cancer imaging and therapy including nanoparticle-mediated drug delivery and hyperthermia.
PURPOSE:Magnetic iron oxide nanoparticles (MNPs) are used as contrast agents for magnetic resonance imaging (MRI) and hyperthermia for cancer treatment. The relationship between MRI signal intensity and cellular iron concentration for many new formulations, particularly MNPs having magnetic properties designed for heating in hyperthermia, is lacking. In this study, we examine the correlation between MRI T2 relaxation time and iron content in cancer cells loaded with various MNP formulations. MATERIALS AND METHODS:Humanprostate carcinomaDU-145 cells were loaded with starch-coated bionised nanoferrite (BNF), iron oxide (Nanomag® D-SPIO), Feridex™, and dextran-coated Johns Hopkins University (JHU) particles at a target concentration of 50 pg Fe/cell using poly-D-lysine transfection reagent. T2-weighted MRI of serial dilutions of these labelled cells was performed at 9.4 T and iron content quantification was performed using inductively coupled plasma mass spectrometry (ICP-MS). Clonogenic assay was used to characterise cytotoxicity. RESULTS: No cytotoxicity was observed at twice the target intracellular iron concentration (∼100 pg Fe/cell). ICP-MS revealed highest iron uptake efficiency with BNF and JHU particles, followed by Feridex and Nanomag-D-SPIO, respectively. Imaging data showed a linear correlation between increased intracellular iron concentration and decreased T2 times, with no apparent correlation among MNP magnetic properties. CONCLUSIONS: This study demonstrates that for the range of nanoparticle concentrations internalised by cancer cells the signal intensity of T2-weighted MRI correlates closely with absolute iron concentration associated with the cells. This correlation may benefit applications for cell-based cancer imaging and therapy including nanoparticle-mediated drug delivery and hyperthermia.
Authors: Dimitrios Karussis; Clementine Karageorgiou; Adi Vaknin-Dembinsky; Basan Gowda-Kurkalli; John M Gomori; Ibrahim Kassis; Jeff W M Bulte; Panayiota Petrou; Tamir Ben-Hur; Oded Abramsky; Shimon Slavin Journal: Arch Neurol Date: 2010-10
Authors: Hakho Lee; Tae-Jong Yoon; Jose-Luiz Figueiredo; Filip K Swirski; Ralph Weissleder Journal: Proc Natl Acad Sci U S A Date: 2009-07-20 Impact factor: 11.205
Authors: Luis C Branquinho; Marcus S Carrião; Anderson S Costa; Nicholas Zufelato; Marcelo H Sousa; Ronei Miotto; Robert Ivkov; Andris F Bakuzis Journal: Sci Rep Date: 2013-10-07 Impact factor: 4.379
Authors: Robert V Stigliano; Fridon Shubitidze; James D Petryk; Levan Shoshiashvili; Alicia A Petryk; P Jack Hoopes Journal: Int J Hyperthermia Date: 2016-07-20 Impact factor: 3.914
Authors: Anilchandra Attaluri; Sri Kamal Kandala; Michele Wabler; Haoming Zhou; Christine Cornejo; Michael Armour; Mohammad Hedayati; Yonggang Zhang; Theodore L DeWeese; Cila Herman; Robert Ivkov Journal: Int J Hyperthermia Date: 2015-03-26 Impact factor: 3.914
Authors: Dana C Baiu; Nathan S Artz; Meghan R McElreath; Bryan D Menapace; Diego Hernando; Scott B Reeder; Cordula Grüttner; Mario Otto Journal: Nanomedicine (Lond) Date: 2015-09-30 Impact factor: 5.307
Authors: Christian Ndong; Seiko Toraya-Brown; Katsiaryna Kekalo; Ian Baker; Tillman U Gerngross; Steven N Fiering; Karl E Griswold Journal: Int J Nanomedicine Date: 2015-04-01